| Metastatic behavior of breast cancer subtypes H Kennecke, R Yerushalmi, R Woods, MCU Cheang, D Voduc, ... Journal of clinical oncology 28 (20), 3271-3277, 2010 | 2592 | 2010 |
| Population-based validation of the prognostic model ADJUVANT! for early breast cancer IA Olivotto, CD Bajdik, PM Ravdin, CH Speers, AJ Coldman, BD Norris, ... Journal of Clinical Oncology 23 (12), 2716-2725, 2005 | 697 | 2005 |
| The impact of new chemotherapeutic and hormone agents on survival in a population‐based cohort of women with metastatic breast cancer SK Chia, CH Speers, Y D'yachkova, A Kang, S Malfair‐Taylor, J Barnett, ... Cancer 110 (5), 973-979, 2007 | 557 | 2007 |
| Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers S Chia, B Norris, C Speers, M Cheang, B Gilks, AM Gown, D Huntsman, ... Journal of Clinical Oncology 26 (35), 5697-5704, 2008 | 435 | 2008 |
| Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer C Lohrisch, C Paltiel, K Gelmon, C Speers, S Taylor, J Barnett, IA Olivotto Journal of clinical oncology 24 (30), 4888-4894, 2006 | 433 | 2006 |
| Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival MCU Cheang, DO Treaba, CH Speers, IA Olivotto, CD Bajdik, SK Chia, ... Journal of clinical oncology 24 (36), 5637-5644, 2006 | 218 | 2006 |
| Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion–negative early breast cancers without adjuvant systemic therapies SK Chia, CH Speers, CJ Bryce, MM Hayes, IA Olivotto Journal of clinical oncology 22 (9), 1630-1637, 2004 | 209 | 2004 |
| Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy PT Truong, IA Olivotto, HA Kader, M Panades, CH Speers, E Berthelet International Journal of Radiation Oncology* Biology* Physics 61 (5), 1337-1347, 2005 | 202 | 2005 |
| Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer L Weir, C Speers, Y D’yachkova, IA Olivotto Journal of clinical oncology 20 (7), 1793-1799, 2002 | 177 | 2002 |
| Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed WD Den Brok, CH Speers, L Gondara, E Baxter, SK Tyldesley, ... Breast cancer research and treatment 161, 549-556, 2017 | 173 | 2017 |
| Comparison of breast cancer recurrence and outcome patterns between patients treated from 1986 to 1992 and from 2004 to 2008 RJD Cossetti, SK Tyldesley, CH Speers, Y Zheng, KA Gelmon Journal of clinical oncology 33 (1), 65-73, 2015 | 171 | 2015 |
| Adjuvant chemotherapy use and outcomes of patients with high‐risk versus low‐risk stage II colon cancer A Kumar, HF Kennecke, DJ Renouf, HJ Lim, S Gill, R Woods, C Speers, ... Cancer 121 (4), 527-534, 2015 | 155 | 2015 |
| Evolving treatment strategies for inflammatory breast cancer: a population-based survival analysis M Panades, IA Olivotto, CH Speers, T Shenkier, TA Olivotto, L Weir, ... Journal of Clinical Oncology 23 (9), 1941-1950, 2005 | 147 | 2005 |
| Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study ML Lesperance, IA Olivotto, N Forde, Y Zhao, C Speers, H Foster, M Tsao, ... Breast cancer research and treatment 76, 137-143, 2002 | 141 | 2002 |
| Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome R Yerushalmi, S Tyldesley, H Kennecke, C Speers, R Woods, B Knight, ... Annals of oncology 23 (2), 338-345, 2012 | 131 | 2012 |
| Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer RDA Peixoto, C Speers, CE McGahan, DJ Renouf, DF Schaeffer, ... Cancer medicine 4 (8), 1171-1177, 2015 | 129 | 2015 |
| Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy PT Truong, M Lesperance, A Culhaci, HA Kader, CH Speers, IA Olivotto International Journal of Radiation Oncology* Biology* Physics 62 (1), 175-182, 2005 | 114 | 2005 |
| Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer IA Olivotto, B Chua, SJ Allan, CH Speers, S Chia, J Ragaz Journal of clinical oncology 21 (5), 851-854, 2003 | 113 | 2003 |
| Time to stop progesterone receptor testing in breast cancer management IA Olivotto, PT Truong, CH Speers, V Bernstein, SJ Allan, SJ Kelly, ... Journal of clinical oncology 22 (9), 1769-1770, 2004 | 111 | 2004 |
| Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer–specific survival in elderly women with breast cancer PT Truong, V Bernstein, M Lesperance, CH Speers, IA Olivotto The American journal of surgery 191 (6), 749-755, 2006 | 109 | 2006 |
Stephen KL ChiaMedical Oncology, British Columbia Cancer AgencyVerified email at bccancer.bc.ca
